Evidence map›Paper›PMID 40723447›Full record

ArticleBiology2025

The V5-Epitope Tag for Cell Engineering and Its Use in Immunohistochemistry and Quantitative Flow Cytometry.

Katja Fritschle, Marion Mielke, Olga J Seelbach, Ulrike Mühlthaler, Milica Živanić, Tarik Bozoglu, Sarah Dötsch, Linda Warmuth, Dirk H Busch, Arne Skerra and 5 more

Abstract read
In one paragraph

Article in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Katja FritschleDepartment of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.
Marion MielkeComparative Experimental Pathology (CEP), School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.
Olga J SeelbachComparative Experimental Pathology (CEP), School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.
Ulrike MühlthalerComparative Experimental Pathology (CEP), School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.
Milica ŽivanićDepartment of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.
Tarik BozogluDeutsches Zentrum für Herz-Kreislaufforschung (DZHK), 80636 Munich, Germany.ORCID 0000-0002-6545-2150
Sarah DötschInstitute for Medical Microbiology, Immunology and Hygiene, School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0003-1712-4619
Linda WarmuthInstitute for Medical Microbiology, Immunology and Hygiene, School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0003-3324-7731
Dirk H BuschInstitute for Medical Microbiology, Immunology and Hygiene, School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0001-8713-093X
Arne SkerraLehrstuhl für Biologische Chemie, School of Life Sciences, Technical University of Munich, 85354 Freising, Germany.ORCID 0000-0002-5717-498X
Christian KupattDeutsches Zentrum für Herz-Kreislaufforschung (DZHK), 80636 Munich, Germany.ORCID 0000-0002-3611-1218
Wolfgang A WeberDepartment of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.
Richard E RandallCentre for Biomolecular Sciences, School of Biology, University of St. Andrews, St. Andrews KY16 9ST, UK.
Katja SteigerComparative Experimental Pathology (CEP), School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0002-7269-5433
Volker MorathDepartment of Nuclear Medicine, TUM University Hospital, School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.ORCID 0000-0001-7636-0537

Funding

National Centre for the 3Rs (NC3Rs) NC/C01905/1 & NC/C019202/1
6 · The paper itself

Abstract

Synthetic biology has fundamentally advanced cell engineering and helped to develop effective therapeutics such as chimeric antigen receptor (CAR)-T cells. For these applications, the detection, localization, and quantification of heterologous fusion proteins assembled from interchangeable building blocks is of high importance. The V5 tag, a 14-residue epitope tag, offers promising characteristics for these applications but has only rarely been used in this context. Thus, we have systematically evaluated the murine anti-V5 tag antibody mu_SV5-Pk1 as well as its humanized version, hu_SV5-Pk1, to analyze cells expressing V5-tagged receptors in samples from various in vitro and in vivo experiments. We found that the V5 tag signal on cells is affected by certain fixation and detachment reagents. Immunohistochemistry (IHC) on formalin-fixed paraffin-embedded (FFPE) mouse tissue samples was performed to sensitively detect cells in tissue. We improved IHC by applying the hu_SV5-Pk1 monoclonal antibody (mAb) to avoid cross-reactivity within and unspecific background signals arising on fixed mouse tissue. Conversely, the absence of unspecific binding by the mu_SV5-Pk1 mAb was evaluated on 46 human normal or cancer tissues. Our findings present a robust toolbox for utilizing the V5 tag and cognate antibodies in synthetic biology applications.

Indexed as

DTPA-Rimmuno-engineeringimmunohistochemistrysynthetic biologyV5 tag

Identifiers

PMID40723447
PMCPMC12292070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.